Screening and diagnostic tools for autism spectrum disorder: Systematic review and meta-analysis
- PMID: 38484581
- PMCID: PMC10951453
- DOI: 10.1016/j.clinsp.2023.100323
Screening and diagnostic tools for autism spectrum disorder: Systematic review and meta-analysis
Abstract
Introduction: Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental disorder, with main manifestations related to communication, social interaction, and behavioral patterns. The slight dynamics of change in the child over time require that the onset of clinical manifestations presented by the child be more valued, with the aim of stabilizing the condition. Faced with a variety of methods for diagnosing ASD, the question arises as to which method should be used. This systematic review aims to recommend the best tools to perform screening and diagnosis.
Methodology: This systematic review followed the PRISMA guidelines. The databases MEDLINE, Embase, CENTRAL (Cochrane), and Lilacs were accessed, and gray and manual searches were performed. The search strategy was created with terms referring to autism and the diagnosis/broad filter. The studies were qualitatively evaluated and quantitatively. Statistical analysis was performed using Meta-diSc-2.0 software, the confidence interval was 95 %.
Results: The M-CHAT-R/F tool demonstrated a sensitivity of 78 % (95 % CI 0.57‒0.91) and specificity of 0.98 (95 % CI 0.88-1.00). The diagnostic tools demonstrated sensitivity and specificity respectively of: ADOS, sensitivity of 87 % (95 % CI 0.79‒0.92) and specificity 75 % (95 % CI 0.73‒0.78); ADI-R demonstrated test sensitivity of 77 % (95 % CI 0.56‒0.90) and specificity 68 % (95 % CI 0.52‒0.81), CARS test sensitivity was 89 % (95 % CI 0.78‒0.95) and specificity 79 % (95 % CI 0.65‒0.88).
Conclusion: It is mandatory to apply a screening test, the most recommended being the M-CHAT-R/F. For diagnosis CARS and ADOS are the most recommended tools.
Keywords: Autism; Children; Diagnosis; Screening.
Copyright © 2023 HCFMUSP. Published by Elsevier España, S.L.U. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflicts of interest.
Figures










Similar articles
-
Overall prognosis of preschool autism spectrum disorder diagnoses.Cochrane Database Syst Rev. 2022 Sep 28;9(9):CD012749. doi: 10.1002/14651858.CD012749.pub2. Cochrane Database Syst Rev. 2022. PMID: 36169177 Free PMC article.
-
Memantine for autism spectrum disorder.Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD013845. doi: 10.1002/14651858.CD013845.pub2. Cochrane Database Syst Rev. 2022. PMID: 36006807 Free PMC article.
-
Parent-mediated early intervention for young children with autism spectrum disorders (ASD).Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD009774. doi: 10.1002/14651858.CD009774.pub2. Cochrane Database Syst Rev. 2013. PMID: 23633377 Free PMC article.
-
Methylphenidate for children and adolescents with autism spectrum disorder.Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2. Cochrane Database Syst Rev. 2017. PMID: 29159857 Free PMC article.
-
Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.Cochrane Database Syst Rev. 2022 Mar 23;3(3):CD010890. doi: 10.1002/14651858.CD010890.pub2. Cochrane Database Syst Rev. 2022. PMID: 35320584 Free PMC article.
Cited by
-
Cognitive Brain Networks and Enlarged Perivascular Spaces: Implications for Symptom Severity and Support Needs in Children with Autism.J Clin Med. 2025 Apr 27;14(9):3029. doi: 10.3390/jcm14093029. J Clin Med. 2025. PMID: 40364061 Free PMC article.
-
Behavioral therapies for the treatment of autism spectrum disorder: A systematic review.Clinics (Sao Paulo). 2024 Dec 26;80:100566. doi: 10.1016/j.clinsp.2024.100566. eCollection 2025. Clinics (Sao Paulo). 2024. PMID: 39729835 Free PMC article.
-
Mapping autism in Egypt: population-based insights into prevalence, risk determinants, and severity among children aged 1-12 years.Mol Autism. 2025 May 29;16(1):32. doi: 10.1186/s13229-025-00665-1. Mol Autism. 2025. PMID: 40442748 Free PMC article.
-
Autism, Diagnostics, and Dementia: A Consensus Report From the 2nd International Summit on Intellectual Disabilities and Dementia.Int J Geriatr Psychiatry. 2025 Jun;40(6):e70110. doi: 10.1002/gps.70110. Int J Geriatr Psychiatry. 2025. PMID: 40481277 Free PMC article. Review.
-
HERVs Endophenotype in Autism Spectrum Disorder: Human Endogenous Retroviruses, Specific Immunoreactivity, and Disease Association in Different Family Members.Microorganisms. 2024 Dec 24;13(1):9. doi: 10.3390/microorganisms13010009. Microorganisms. 2024. PMID: 39858776 Free PMC article. Review.
References
-
- American Psychiatric Publishing; Arlington (VA): 2013. American psychiatric association. diagnostic and statistical manual of mental disorders. 5th edition(DSM-5)
-
- Hyman S.L., Levy S.E., Myers S.M. Council on children with disabilities, section on developmental and behavioral pediatrics. identification, evaluation, and management of children with autism spectrum disorder. Pediatrics. 2020;145(1) - PubMed
-
- Crespin G. 1st edition. Casa do Psicólogo; São Paulo: 2004. The early clinic: the birth of the human.
-
- Van't Hof M., Tisseur C., Van Berckelear-Onnes I., Van Nieuwenhuyzen A., Daniels A.M., Deen M., et al. Age at autism spectrum disorder diagnosis: a systematic review and metaanalysis from 2012 to 2019. Autism. 2021;25(4):862–867. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical